📢 NEWS: We’re collaborating with Biolojic Design to leverage the company’s #AI capabilities to design therapeutic antibodies for the treatment of cancer and immunological disorders. ms.spr.ly/6011YmPmv #Oncology #Immunology

Discover how our research in DDR inhibition may offer potential new targeted approaches with the opportunity to innovate #cancer treatment on June 3. (abstract 3018). ms.spr.ly/6017YmTiP #ASCO24 ASCO

In locally advanced #HeadAndNeckCancer, the goal of treatment is to eradicate the disease, but many patients will experience a recurrence within two years of treatment. With our research, we’re working to improve outcomes for patients. Learn more: ms.spr.ly/6018YmTWw #ASCO24

#DYK our Fertility LifeLines is geared toward helping #fertility patients of ALL kinds? Whether you’re undergoing #IVF, surrogacy, #eggfreezing, or other treatment, we're here to support you. See if you may be eligible for one of our savings programs: ms.spr.ly/6010YU710

At our advocacy reception at #ASCO24, we connected with patient advocacy groups about the importance of the caregiver in cancer. Thanks to the Elizabeth Dole Foundation for sharing the work they do in raising awareness about the needs of caregivers. ASCO

Looking back at #ASCO24, we're inspired by the great progress we're making in the field of oncology. Together, we're forging a future where more cancer patients become cancer survivors. Hear from one of our oncology leaders on his highlights. ms.spr.ly/6015YAgwH ASCO

Allison Catherino has a wealth of personal and professional knowledge on #fertility treatment, which she recently shared with Medium/Authority Magazine. Check out her insights on all things #IVF: ms.spr.ly/6011YCjM5

See you on July 10, Gryt Health!

How can we enhance access to #biomarker testing for #NSCLC patients? Register for "Understanding the Challenges of Universal Biomarker Testing: A Regional Pilot for NSCLC" today: ms.spr.ly/6011l8SDv Gryt Health #NSCLC #LungCancer #Biomarkers

Our team contributed to 10 sessions in critical topics at the Drug Information Association (DIA) Global Annual Meeting, such as enhancing patient engagement, the impact of racial discrimination on #ClinicalTrials & exploring the promise of #GenAI in pharmacovigilance. #AsOneForPatients #DIA2024

IMC is pleased to share that Javed Alam, Managing Director, EMD Serono, has joined our Board of Directors! With 26+ years of experience contributing to the global healthcare landscape, he has held numerous leadership roles in multinational healthcare companies around the globe.

We're proud to join the #CancerCaregivingCollaborative to uplift family caregivers in cancer care. Together we’ll focus on integrating caregivers in care teams & championing financial supports to make cancer care more equitable. ms.spr.ly/6014lnair #CancerCaregiving

📢 #News: Today, we announced the first patient dosed in a Phase III study evaluating an oral treatment for generalized #MyastheniaGravis, a rare, chronic autoimmune disorder. Learn more: bit.ly/3X6zPtX #HCPsOnly

Join us in recognizing the latest research in #LungCancer at #WCLC24. Visit booth 418 to learn more about our commitment to advancing science to offer new hope for patients. IASLC #LCSM

Hello, Boston! 👋 We’re getting settled into our U.S. Healthcare headquarters and we’re delighted to be in this global hub of innovation. See the excitement for yourself in this video.

📢 #ESMO24 is just around the corner and our team has been busy preparing for the presentation of the latest research representing our #oncology portfolio. We can’t wait to see everyone there! cslide.ctimeetingtech.com/esmo2024/atten…

Hear from our oncology leaders on why they’re excited for #ESMO24. From sponsoring symposia to presenting oncology data, we’re eager to collaborate with the global #cancer community to help improve the future for patients. cslide.ctimeetingtech.com/esmo2024/atten…

📣 NEWS: At #ECTRIMS, new data will be presented in #MultipleSclerosis, including central inflammation data and real-world evidence drawn from multiple four-year sub-studies. Find out more: tinyurl.com/ykn65cur

We’re exploring the potential of #DDR inhibitor combinations to synergistically enhance synthetic lethality and increase #cancer cell death. Join us at #ESMO24 on September 15 in Hall 6 for insights into our latest research (presentation 193P): tinyurl.com/mvmrjkd7 #HCPsOnly

Intrigued by our ADC data at #ASCO24? We’re presenting longer follow-up data and new biomarker analysis from our Phase I study at #ESMO24 on September 16 (presentation 573P): tinyurl.com/mvmrjkd7 #ScienceOfCancer #HCPsOnly